United States pharmaceutical market middlemans are not a significant reason for the high rates that Novo Nordisk declares, states specialist and previous chief executive officer of Novo Nordisk.
发布者:BY MARKETWIRE,转转请注明出处:https://robotalks.cn/novo-nordisks-defense-of-high-drug-prices-is-called-a-red-herring/